Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-511

I'm not convinced they are conducting a full investigation.

Seems they already have investigated and I could not see any suggestion that they will look into any further from the article, or from any other press that I have come across to date.

"There are many theories being thrown around various investor forums right now, including the fact that perhaps there was a labelling, distribution or packing issue that caused some of the actual BTX1503 dose to be given under the guise of being a "vehicle only" dose. To be clear, the company is saying this did NOT happen, and have put the manufacturing issue down to two key facts:

1. They had to produce the doses in the US (as the DEA forbid them importing the Australian doses) and had to "start from scratch"
2. Given that no one had the experience or scale to produce enough synthetic CBD and Permetrex formulations, they could not outsource to just one provider and had to outsource to various suppliers, with the end result being 11 different batches produced for the purposes of the US study.